Transaction #4701 · Form 4 · 0001628280-25-048856
PRECISION BIOSCIENCES INC · Exercise / conversion · Common Stock
PRECISION BIOSCIENCES INC · Transacted November 2, 2025 · Filed November 4, 2025
What does this filing report?
An SEC Form 4 filing for PRECISION BIOSCIENCES INC records an exercise / conversion involving Common Stock on November 2, 2025. The reported quantity was 1,835. The filing date is November 4, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- PRECISION BIOSCIENCES INC
- Company CIK
- 0001357874
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 1,835
- Reported price
- 0 · See footnotes
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 28,923
- Ownership description
- Not reported
- SEC acceptance time
- Nov 4, 2025, 4:15 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Scimeca Dario ↗
General Counsel and Secretary
CIK 0001779581
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2025.
- F2
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F3
- Includes 2,088 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $4.26.
- F4
- The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- F5
- On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.